Showing results (71-80 of 156) with videos related to
Sort By:
Pageof 16
Scientific Reports|April 6, 2018
Toxigenic effects of two benthic diatoms upon grazing activity of the sea urchin: morphological, metabolomic and de novo transcriptomic analysisNadia Ruocco, Susan Costantini, Valerio Zupo, et al.International Journal of Molecular Sciences|October 10, 2017
Evaluating the Effects of an Organic Extract from the Mediterranean Sponge Geodia cydonium on Human Breast Cancer Cell LinesSusan Costantini, Eliana Guerriero, Roberta Teta, et al.International Journal of Pharmaceutics|July 5, 2016
Biotin-targeted Pluronic(®) P123/F127 mixed micelles delivering niclosamide: A repositioning strategy to treat drug-resistant lung cancer cellsAnnapina Russo, Diogo Silva Pellosi, Valentina Pagliara, et al.Journal of Cellular Physiology|December 29, 2006
R115777 (Zarnestra)/Zoledronic acid (Zometa) cooperation on inhibition of prostate cancer proliferation is paralleled by Erk/Akt inactivation and reduced Bcl-2 and bad phosphorylationMichele Caraglia, Monica Marra, Carlo Leonetti, et al.Proteomics|July 16, 2011
Proteomic analysis identifies differentially expressed proteins after HDAC vorinostat and EGFR inhibitor gefitinib treatments in Hep-2 cancer cellsLaura Bianchi, Francesca Bruzzese, Alessandra Leone, et al.Journal of Experimental & Clinical Cancer Research : CR|December 8, 2017
Synergistic antitumor interaction between valproic acid, capecitabine and radiotherapy in colorectal cancer: critical role of p53Manuela Terranova-Barberio, Biagio Pecori, Maria Serena Roca, et al.International Journal of Molecular Sciences|October 27, 2020
Targeting Autophagy in Breast CancerStefania Cocco, Alessandra Leone, Michela Piezzo, et al.Drugs & Aging|March 16, 2025
A Post Hoc Analysis of Older Patients with Metastatic Colorectal Cancer Receiving Oxaliplatin-Based Chemotherapy Plus Bevacizumab: The Randomized Obelics StudyGerardo Rosati, Maria Carmela Piccirillo, Guglielmo Nasti, et al.Cell Cycle (Georgetown, Tex.)|December 19, 2013
Pharmacological targeting of p53 through RITA is an effective antitumoral strategy for malignant pleural mesotheliomaDomenico Di Marzo, Iris Maria Forte, Paola Indovina, et al.The Journal of Investigative Dermatology|October 19, 2007
The multidrug transporter P-glycoprotein: a mediator of melanoma invasion?Marisa Colone, Annarica Calcabrini, Laura Toccacieli, et al.Pageof 16